Compile Data Set for Download or QSAR
maximum 50k data
Found 1932 with Last Name = 'kulkarni' and Initial = 'ss'
TargetMetabotropic glutamate receptor 5(Homo sapiens (Human))
National Institute On Drug Abuse-Intramural Research Program

Curated by ChEMBL
LigandPNGBDBM50258612(3-Fluoro-5-cyano-1-(2-methylthiazol-4-ylethynyl)be...)
Affinity DataKi:  0.900nMAssay Description:Displacement of [3H]MPEP from cloned mGluR5 (unknown origin) expressed in HEK293T cells by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
National Institute On Drug Abuse-Intramural Research Program

Curated by ChEMBL
LigandPNGBDBM22199(1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-[(2E)-3-...)
Affinity DataKi:  0.900nMAssay Description:Binding affinity at dopamine transporter in rat brain by [3H]WIN-35428 displacement.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656591(N-ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656598(N-ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656599(US11919901, Compound 11 | tert-butyl ((3R,6S)-6-((...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656601(5-fluoro-N,N-diisopropyl-2-((4-(7-(((2S,5R)-5- (me...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656602(2-((4-(7-(((2S,5R)-5-(ethylsulfonamido)tetrahydro-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656610(5-fluoro-N,N-diisopropyl-2-((4-(7-(((2S,5R)-5-((1-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656611(2-((4-(7-(((2S,5R)-5- (cyclopropanesulfonamido)tet...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656612(5-fluoro-N,N-diisopropyl-2-((4-(7-(((2S,5R)-5- (ox...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656613(US11919901, Compound 17 | tert-butyl ((3R,6S)-6-((...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656623(N-cyclopropyl-5-fluoro-N-isopropyl-2-((4-(7- (((2S...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656624(N-cyclopropyl-2-((4-(7-(((2S,5R)-5- (ethylsulfonam...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656625(N-cyclopropyl-5-fluoro-N-isopropyl-2-((4-(7- (((2S...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656626(2-((4-(7-(((2S,5R)-5- (cyclopropanesulfonamido)tet...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656627(N-cyclopropyl-5-fluoro-N-isopropyl-2-((4-(7- (((2S...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656628(N-((3R,6S)-6-((2-(5-(2-((3S,5R)-3,5- dimethylmorph...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656629(N-((3R,6S)-6-((2-(5-(2-((3S,5R)-3,5- dimethylmorph...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656630(N-((3R,6S)-6-((2-(5-(2-((3S,5R)-3,5- dimethylmorph...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656631(N-((3R,6S)-6-((2-(5-(2-((3S,5R)-3,5- dimethylmorph...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656633(N-((3R,6S)-6-((2-(5-(2-((3R,5R)-3,5- dimethylmorph...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656634(N-(3R,6S)-6-((2-(5-(2-((3R,5R)-3,5- dimethylmorpho...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656635(N-(3R,6S)-6-((2-(5-(2-((3R,5R)-3,5- dimethylmorpho...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656636(N-((3R,6S)-6-((2-(5-(2-((3R,5R)-3,5- dimethylmorph...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656637(N-(3R,6S)-6-((2-(5-(2-((3R,5R)-3,5- dimethylmorpho...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656638(2-((4-(7-(((2S,5R)-5-(ethylsulfonamido)tetrahydro-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656639(N-(2,2-difluoroethyl)-2-((4-(7-(((2S,5R)-5- (ethyl...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656640(2-((4-(7-(((2S,5R)-5-(ethylsulfonamido)tetrahydro-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656641(N-((3R,6S)-6-((2-(5-(2-((2S,6R)-2,6- dimethylpiper...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656642(N-ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656644(N-ethyl-2-((4-(7-(((2S,5R)-5-(3- ethylureido)tetra...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656646(2-((4-(7-(((2S,5R)-5-(3-(2,2- difluoroethyl)ureido...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656648(N-(2-cyanoethyl)-2-((4-(7-(((2S,5R)-5- (ethylsulfo...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656649(N-(3,3-difluorocyclobutyl)-2-((4-(7-(((2S,5R)-5- (...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656650(N-ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656651(2-((4-(7-(((2S,5R)-5-(ethylsulfonamido)tetrahydro-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656652(2-((4-(7-(((2S,5R)-5- (cyclopropanesulfonamido)tet...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656653(2-((4-(7-(((2S,5R)-5-(ethylsulfonamido)tetrahydro-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656654(2-((4-(7-(((2S,5R)-5-((N,N- dimethylsulfamoyl)amin...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656655(2-((4-(7-(((2S,5R)-5-(ethylsulfonamido)tetrahydro-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656658(Fluoro-N-isopropyl-N-methyl-2-((4-(7-(((2S,5R)-5- ...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656659(5-Fluoro-N-isopropyl-N-methyl-2-((4-(7-(((2S,5R)- ...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656660(N-Ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656661(N-Ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656662(2-((4-(7-(((2S,5R)-5-((3- Chlorophenyl)sulfonamido...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656663(N-ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656664(2-((4-(7-(((2S,5R)-5-((2- Chlorophenyl)sulfonamido...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656665(N-ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656666(2-((4-(7-(((2S,5R)-5-((4- Chlorophenyl)sulfonamido...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase 2A/Menin(Homo sapiens (Human))
Syndax Pharmaceuticals, Inc.; Vitae Pharmaceuticals, LLC

US Patent
LigandPNGBDBM656667(N-Ethyl-5-fluoro-N-isopropyl-2-((4-(7-(((2S,5R)-5-...)
Affinity DataKi: <1nMAssay Description:Table 4: For Ki determination, individual compounds were prepared as 10 mM DMSO stock solutions. Considering DMSO as the vehicle in the assay system....More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 1932 total ) | Next | Last >>
Jump to: